RAPT Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 107918 min ago

@ $24.99

Wydano: 13 vas. 2024 @ 22:43

Zwrot: -67.59%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: 0.73 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	294 633
Średni wolumen	1.35M
Kapitalizacja rynkowa	281.86M
EPS	$0 ( 2024-03-12 )
Następna data zysków	( $-0.780 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.66
ATR14	$0.0110 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Robbins Wendye	Buy	6 925	Stock Option (right to buy)
2024-03-28	Gray Mary Ann	Buy	8 574	Stock Option (right to buy)
2024-03-28	Rieflin William Jl	Buy	11 871	Stock Option (right to buy)
2024-01-31	Ho William	Buy	75 000	Employee Stock Option (right to buy)
2024-01-31	Young Rodney Kb	Buy	90 000	Employee Stock Option (right to buy)

INSIDER POWER
94.05
Last 100 transactions
Buy: 3 742 359 \| Sell: 63 895

Wolumen Korelacja

Długi: -0.07 (neutral)

Krótki: -0.76 (moderate negative)

Signal:(31.973) Neutral

Rapt Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
RDUS	0.903
ICON	0.901
ATCX	0.9
SYKE	0.898
PAE	0.889
BRACU	0.886
RCON	0.884
CLBT	0.884
ABNB	0.878
DKNG	0.876

10 Najbardziej negatywne korelacje
VIEW	-0.886
SBBP	-0.863
TUEM	-0.855
LGHL	-0.855
ARDS	-0.848
LCAP	-0.844
RPTX	-0.839
AHPI	-0.839
MTEX	-0.838
NAKD	-0.838

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Rapt Therapeutics Inc Korelacja - Waluta/Towar

-0.58
( weak negative )

-0.62
( weak negative )

0.00
( neutral )

-0.52
( weak negative )

0.00
( neutral )

0.25
( neutral )

Rapt Therapeutics Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-3.55M (0.00 %)
EPS:	$-3.05

FY	2023
Przychody:	$0
Zysk brutto:	$-3.55M (0.00 %)
EPS:	$-3.05

FY	2022
Przychody:	$1.53M
Zysk brutto:	$-1.28M (-83.82 %)
EPS:	$-2.52

FY	2021
Przychody:	$3.81M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.53

Financial Reports:

No articles found.

Rapt Therapeutics Inc

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.